Press Releases

 Filter by Provider

Demonstrates 99.9% two-qubit gate fidelity at 28 nanosecond gate speed on prototype platform

Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading global manufacturer and provider of turnkey self-storage, commercial, and industrial building solutions, today announced financial results for its fiscal fourth quarter and full year ended January 3, 2026.

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the quarter and year ended December 31, 2025, and provided operating and partner program updates.

Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in wireless universal control solutions for home entertainment and smart home devices, will host a conference call at 4:30 p.m. ET on Thursday, March 12, 2026, to discuss its fourth quarter 2025 financial results. Management will provide a financial and business update as well as answer questions.

When most Australians hear the word “quantum”, they think of something futuristic. A lab experiment. A distant breakthrough. Perhaps something to do with quantum computers...?

Paragon Announces Final Resolution of Legacy Litigation Liabilities Created by Prior Board

WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in the 2026 RBC Capital Markets Global Financial Institutions Conference on March 11, 2026, in New York City. David Burg, Executive Vice President, Chief Financial Officer, Arthur J. Bacci, Executive Vice President, Chief Operating Officer, and Andrew Basile, Vice President, Head of Investor Relations will host discussions with investors.

CHAPEL HILL, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Kelly Hadiaris has re-joined the Company as Senior Vice President, Underwriting – Excess Casualty, to lead the Excess Casualty division within its Excess and Surplus (“E&S”) segment. Ms. Hadiaris will report to Todd Sutherland, President of the E&S segment.

Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn Capital

MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the fourth quarter and full year ended December 31, 2025 and raised guidance for full year 2026.

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.

SAXONBURG, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its CHR1074 224Gbps quad-channel transimpedance amplifier (TIA) designed to power next-generation 800G and 1.6T optical transceivers. Engineered for high-performance AI and cloud infrastructure, the CHR1074 combines ultra-fast link recovery with intelligent power management to improve efficiency and reduce latency in increasingly dynamic data center environments.

Fourth Quarter Results

Fourth Quarter Revenue Increased 20% to a Record $23.4 Million

IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steven Perrin, Ph.D., President and Chief Scientific Officer, will participate in a fireside chat at the upcoming Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026, at 1:40 p.m. ET (10:40 a.m. PT).

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on March 2, 2026, the Company granted restricted stock units (RSUs) representing 50,700 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.

Free global platform provides healthcare professionals with 1,000+ premium courses and clinical images, including specialized training on AI-enhanced ultrasound diagnostics

MWC Barcelona 2026 offers a clear preview of what is coming next as artificial intelligence and 5G converge to reshape the wireless industry. Each year, global trade shows like Mobile World Congress in Barcelona usher in new thinking, fresh ideas, and breakthrough technologies for the wireless industry. In 2026, AI and 5G stand side by side, with powerful demonstrations of how they will transform both the industry and our everyday lives.

Smith Micro Software, Inc. (Nasdaq: SMSI) today announced that it has named current Chief Operating Officer and Chief Financial Officer Tim Huffmyer to serve as Smith Micro’s next President and Chief Executive Officer. Huffmyer will assume the role from Bill Smith, who has been appointed to the role of Executive Chairman. The changes will take effect on March 31, 2026 and follow leadership succession planning led by Smith and the Company’s Board of Directors.

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological diseases, today announced regulatory updates related to the FREEDOM2 trial.

Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced its fourth quarter and fiscal year 2025 financial results.

Cardlytics, Inc. (NASDAQ: CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025.

Smith Micro Software, Inc. (the “Company” or “Smith Micro”) (NASDAQ: SMSI) today announced that it has entered into a securities purchase agreement for the sale of securities to accredited investors pursuant to an unregistered offering, the gross proceeds of which are expected to be approximately $4.9 million, which includes committed investments of approximately $4.6 million from a trust for which Bill Smith, the Company’s chief executive officer and founder, serves as co-trustee, and approximately $90 thousand from Tim Huffmyer, the Company’s chief operating officer and chief financial officer.

Boynton Beach, FL - As homeowners across South Florida invest in home improvements that enhance both comfort and property value, experts at Sunline Kitchen Remodeling are encouraging residents to plan a professional Kitchen Remodel to modernize outdated kitchens and improve daily functionality. According to housing industry reports, kitchen renovations remain one of the most valuable home upgrades, often delivering some of the highest returns on investment among residential improvement projects.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that Alexion Pharmaceuticals, Inc. (the “Licensee”) informed Xencor, Inc. (the “Company”) that it has taken the position that the Licensee does not owe any additional royalties for sales of Ultomiris® (ravulizumab-cwvz) in the United States and that the Licensee does not intend to make any future payments for sales in the United States. The Licensee informed the Company that it intends to continue making royalty payments for sales of Ultomiris outside the United States.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three months and full year ended December 31, 2025, and highlighted recent progress.

Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced financial results for the fourth quarter and full year 2025.

Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of magnetoresistive random access memory (MRAM) persistent memory solutions, today announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Smith Micro Software, Inc. (Nasdaq: SMSI) (“Smith Micro” or the “Company”) today reported financial results for its fourth quarter and fiscal year ended December 31, 2025.

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.

Okta, Inc. (Nasdaq: OKTA), the leading independent identity partner, today announced financial results for its fourth quarter and fiscal year ended January 31, 2026.

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, will hold a conference call on Thursday, March 12, 2026 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2025, and will be providing updates on its key strategic growth initiatives, specifically the limited commercial launch and significant developments on the 12-lead ECG extended wear patch. A press release detailing these results will be issued prior to the call.

Mechelen, Belgium; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.

EMERYVILLE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the fourth quarter and full fiscal year ended January 3, 2026, both of which contained one additional week ("53rd week") versus the comparable prior periods. Additionally, the Company today announced a business optimization plan (the “Optimization Plan”) to improve operational execution, strengthen long-term profitability and increase cash flow generation.

BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on March 2, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 2,931 shares of its common stock to fourteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on March 1, 2026, the Company granted inducement awards to purchase up to 81,600 shares of common stock to three new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a progress update on the Company's key 2026 objectives.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Board of Directors Reconstituted With Anita Wood as Chairman; Company Positioned for Continued Growth and Commercialization 

Smart calendar with no subscription fees sync with Google Calendar to ease the mental load on parents, and are now $35 off for the Spring Sale.

NioCorp Management and Special Guest to Provide Update on the Launch of Construction of Mine Portal at the Elk Creek Critical Minerals Project in Nebraska

Discover the New Spring Collection from Catch Phrase Poet Clothing

BBB National Programs’ Digital Advertising Accountability Program (DAAP) worked with Audiomob to update its privacy policy and in-app notices to bring its platform and third-party interest-based advertising (IBA) into compliance with the Digital Advertising Alliance’s (DAA) Self-Regulatory Principles.

Pivot Bio, one of the world’s leading, innovative agtech companies, today announced it has moved its corporate headquarters to Minneapolis, Minn., relocating from its prior headquarters in Berkeley, Calif. This move further strengthens the company’s presence in the U.S. agricultural heartland.

BROOKINGS, S.D., March 04, 2026 (GLOBE NEWSWIRE) -- Daktronics, Inc. (NASDAQ-DAKT), the leading U.S.-based designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, today announced it will host its 2026 Investor Day on Thursday, April 9, at the home of the NASDAQ MarketSite in Times Square.

COLORADO - Sean Oblizalo, the Colorado-based elopement photographer and planner behind Vows and Peaks, offers a tiered suite of Colorado Elopement Packages giving couples a clear, stress-free path to getting married in the mountains on their own terms.

A sweeping, masterfully crafted work of historical fiction, Ghosts of the Revolutionary War: The Journal of a 21st Century Man Who Travels Back in Time to 1780 stands as a bold and intellectually rich contribution to Revolutionary War literature. This extraordinary novel merges elite scholarship, military expertise, and imaginative brilliance into a truly unforgettable reading experience.

The new report details how life sciences organizations are responding to regulatory change, resource constraints, and fragmented systems.

Bobbie, the mom-founded pediatric nutrition company, today announced that its complete line of organic and grass-fed infant formulas has been named "Top Choices" by Consumer Reports, the leading independent, nonprofit consumer advocacy organization. In two consecutive rounds of independent formula safety testing — conducted in March 2025 and March 2026 — Consumer Reports found non-detectable to low levels of heavy metals and toxins across all four of Bobbie's infant formulas, making Bobbie one of the only formula brands to achieve top-choice status across its entire product line in both rounds of testing.